BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Xenome Ltd Release: Addition To US Patent Portfolio For Xen2174

  April 23, 2009

   · 

  1 min read
• FDA

  China Sky One Medical, Inc. Obtains SFDA Approvals for Geranium Ointment and Musk Liniment for Pain Relief

  April 23, 2009

   · 

  3 min read
• Biotech Bay

  Fructose-Sweetened Beverages Linked to Heart Risks

  April 23, 2009

   · 

  1 min read
• Business

  Zimmer Holdings Inc. Profit Falls 16 Pct, Beats Street View

  April 23, 2009

   · 

  1 min read
• Business

  Novartis AG Profit Falls 15% on Stronger Dollar, Finance Costs

  April 23, 2009

   · 

  1 min read
• Drug Development

  Salix Pharmaceuticals, Ltd. Presents Highly Statistically Significant Results from the Phase III Pivotal Study of Rifaximin for the Prevention and Maintenance of Remission of Hepatic Encephalopathy (HE)

  April 23, 2009

   · 

  11 min read
• Business

  ConMed Corporation Posts Lower Q1 Profit, Cuts ’09 View

  April 23, 2009

   · 

  1 min read
• Business

  Quidel Corporation Posts Wider-Than-Expected Q1 Loss

  April 23, 2009

   · 

  1 min read
• Business

  PDI, Inc. Announces Termination of Promotion Agreement with Novartis Corporation

  April 23, 2009

   · 

  4 min read
• BioCapital

  AstraZeneca PLC and Bristol-Myers Squibb Company Diabetes Drug Onglyza Faces FDA Delay; PDUFA Extended to July 30

  April 23, 2009

   · 

  4 min read